Express Delivery
All orders are shipped with Econt
Cash on delivery
Reliable and convenient payment methods
Proven quality
Peptides Tested at Janoshik Labs
Express delivery in 1-3 business days.
Each peptide comes with bacteriostatic water.
DSIP (Delta Sleep-Inducing Peptide) is a naturally occurring neuropeptide, first discovered in mammalian brain tissue in the 1970s. It is an octapeptide that has been studied in scientific literature for its role in sleep regulation, stress response, and neuroendocrine balance. In research settings, DSIP has been investigated as a modulator of homeostatic processes related to sleep, cortisol levels, and adaptation to psychophysiological stress.
In preclinical and clinical studies, DSIP has been of interest for its potential to promote deep (slow-wave) sleep, stabilize circadian rhythms, and reduce excessive cortisol secretion. Some studies also consider DSIP as a co-regulator of other neurohormones – somatotropin, prolactin, and ACTH – in the body's adaptation to exertion, overwork, and chronic stress.
In scientific literature, DSIP has been studied for its possible role in:
Improving sleep quality – promoting deep sleep and stabilizing circadian rhythms
Regulating cortisol levels – potential effect on stress response and homeostasis
Supporting neuroendocrine function – balancing the secretion of hormones involved in sleep and adaptation
Neuroprotection – potential antioxidant and anti-stress effect on the central nervous system
Stimulating restorative processes – studied in cases of physical and mental overexertion
Mood modulation – some studies discuss its involvement in serotonergic regulation
In scientific literature, subcutaneous administration of 100-300 μg daily, usually in the evening before sleep, has been described. It is used for studying neuroendocrine mechanisms, without an approved therapeutic dose.
For 5 mg + 3 ml bacteriostatic water:
Concentration = 1.67 mg/ml → 0.06 ml = 100 μg
Example values:
0.06 ml = 100 μg
0.12 ml = 200 μg
0.18 ml = 300 μg
0.24 ml = 400 μg
0.3 ml = 500 μg
DSIP has been studied in various fields - neuroscience, psychoneuroendocrinology, sports physiology, and gerontology.
In sleep studies, an increase in deep phases (NREM) and better sleep quality have been observed
In stress and fatigue models, a reduction in cortisol and an improvement in recovery indicators have been reported
In chronic exertion, DSIP has been studied for its effect on neuroendocrine balance and adaptation
In neurology, its potential neuroprotective function against oxidative stress is considered
In sports medicine, it is analyzed as a factor for faster recovery in cases of insufficient sleep
DSIP is not intended for use in sports, but in scientific literature, it is considered for its potential role in adaptation to exertion and sleep regulation in actively training individuals. Due to its possible influence on cortisol and recovery, DSIP is included in the list of peptides subject to control by WADA for professional athletes.
May help normalize sleep during intense training regimens
Is being investigated as a possible factor for better adaptation to chronic fatigue
Potential synergy with peptides regulating the GH/IGF-1 axis
In scientific literature, DSIP is generally well-tolerated. Reported reactions are rare and dose-dependent:
Transient drowsiness or fatigue after administration
Mild dizziness or drop in blood pressure
Headache, hot flashes, or a feeling of relaxation
At higher doses, isolated cases of mild hypotension and reduced concentration are observed due to its sedative effect.
The information is based on published scientific sources and is entirely for educational purposes. It is not intended for the diagnosis, treatment, or prevention of diseases.